281 related articles for article (PubMed ID: 30312106)
1. Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension.
Nikolic I; Yung LM; Yang P; Malhotra R; Paskin-Flerlage SD; Dinter T; Bocobo GA; Tumelty KE; Faugno AJ; Troncone L; McNeil ME; Huang X; Coser KR; Lai CSC; Upton PD; Goumans MJ; Zamanian RT; Elliott CG; Lee A; Zheng W; Berasi SP; Huard C; Morrell NW; Chung RT; Channick RW; Roberts KE; Yu PB
Am J Respir Crit Care Med; 2019 Apr; 199(7):891-902. PubMed ID: 30312106
[TBL] [Abstract][Full Text] [Related]
2. Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis.
Owen NE; Alexander GJ; Sen S; Bunclark K; Polwarth G; Pepke-Zaba J; Davenport AP; Morrell NW; Upton PD
EBioMedicine; 2020 Jun; 56():102794. PubMed ID: 32454407
[TBL] [Abstract][Full Text] [Related]
3. Characterization of
Hodgson J; Swietlik EM; Salmon RM; Hadinnapola C; Nikolic I; Wharton J; Guo J; Liley J; Haimel M; Bleda M; Southgate L; Machado RD; Martin JM; Treacy CM; Yates K; Daugherty LC; Shamardina O; Whitehorn D; Holden S; Bogaard HJ; Church C; Coghlan G; Condliffe R; Corris PA; Danesino C; Eyries M; Gall H; Ghio S; Ghofrani HA; Gibbs JSR; Girerd B; Houweling AC; Howard L; Humbert M; Kiely DG; Kovacs G; Lawrie A; MacKenzie Ross RV; Moledina S; Montani D; Olschewski A; Olschewski H; Ouwehand WH; Peacock AJ; Pepke-Zaba J; Prokopenko I; Rhodes CJ; Scelsi L; Seeger W; Soubrier F; Suntharalingam J; Toshner MR; Trembath RC; Vonk Noordegraaf A; Wort SJ; Wilkins MR; Yu PB; Li W; Gräf S; Upton PD; Morrell NW
Am J Respir Crit Care Med; 2020 Mar; 201(5):575-585. PubMed ID: 31661308
[No Abstract] [Full Text] [Related]
4. Regulation of the ALK1 ligands, BMP9 and BMP10.
Li W; Salmon RM; Jiang H; Morrell NW
Biochem Soc Trans; 2016 Aug; 44(4):1135-41. PubMed ID: 27528761
[TBL] [Abstract][Full Text] [Related]
5. The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan.
Takahashi Y; Yamamoto K; Sakao S; Takeuchi T; Suda R; Tanabe N; Tatsumi K
BMC Pulm Med; 2021 Mar; 21(1):89. PubMed ID: 33726742
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
Upton PD; Davies RJ; Trembath RC; Morrell NW
J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
[TBL] [Abstract][Full Text] [Related]
7. Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells.
Szulcek R; Sanchez-Duffhues G; Rol N; Pan X; Tsonaka R; Dickhoff C; Yung LM; Manz XD; Kurakula K; Kiełbasa SM; Mei H; Timens W; Yu PB; Bogaard HJ; Goumans MJ
Angiogenesis; 2020 Nov; 23(4):699-714. PubMed ID: 32813135
[TBL] [Abstract][Full Text] [Related]
8. What's new in the treatment of portopulmonary hypertension?
DuBrock HM; Channick RN; Krowka MJ
Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):983-92. PubMed ID: 25882070
[TBL] [Abstract][Full Text] [Related]
9. Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension.
Tu L; Desroches-Castan A; Mallet C; Guyon L; Cumont A; Phan C; Robert F; Thuillet R; Bordenave J; Sekine A; Huertas A; Ritvos O; Savale L; Feige JJ; Humbert M; Bailly S; Guignabert C
Circ Res; 2019 Mar; 124(6):846-855. PubMed ID: 30636542
[TBL] [Abstract][Full Text] [Related]
10. Portopulmonary Hypertension: Management and Liver Transplantation Evaluation.
DuBrock HM
Chest; 2023 Jul; 164(1):206-214. PubMed ID: 36649754
[TBL] [Abstract][Full Text] [Related]
11. Other causes of PAH (schistosomiasis, porto-pulmonary hypertension and hemolysis-associated pulmonary hypertension).
Souza R; Fernandes CJ; Jardim CV
Semin Respir Crit Care Med; 2009 Aug; 30(4):448-57. PubMed ID: 19634084
[TBL] [Abstract][Full Text] [Related]
12. Portopulmonary hypertension.
Krowka MJ
Semin Respir Crit Care Med; 2012 Feb; 33(1):17-25. PubMed ID: 22447257
[TBL] [Abstract][Full Text] [Related]
13. Pediatric pulmonary arterial hypertension due to a novel homozygous GDF2 missense variant affecting BMP9 processing and activity.
Chomette L; Hupkens E; Romitti M; Dewachter L; Vachiéry JL; Bailly S; Costagliola S; Smits G; Tillet E; Bondue A
Am J Med Genet A; 2023 Aug; 191(8):2064-2073. PubMed ID: 37249087
[TBL] [Abstract][Full Text] [Related]
14. BMP9/10 in Pulmonary Vascular Complications of Liver Disease.
Rochon ER; Krowka MJ; Bartolome S; Heresi GA; Bull T; Roberts K; Hemnes A; Forde KA; Krok KL; Patel M; Lin G; McNeil M; Al-Naamani N; Roman BL; Yu PB; Fallon MB; Gladwin MT; Kawut SM
Am J Respir Crit Care Med; 2020 Jun; 201(12):1575-1578. PubMed ID: 32083953
[No Abstract] [Full Text] [Related]
15. Portopulmonary hypertension in the current era of pulmonary hypertension management.
Savale L; Guimas M; Ebstein N; Fertin M; Jevnikar M; Renard S; Horeau-Langlard D; Tromeur C; Chabanne C; Prevot G; Chaouat A; Moceri P; Artaud-Macari É; Degano B; Tresorier R; Boissin C; Bouvaist H; Simon AC; Riou M; Favrolt N; Palat S; Bourlier D; Magro P; Cottin V; Bergot E; Lamblin N; Jaïs X; Coilly A; Durand F; Francoz C; Conti F; Hervé P; Simonneau G; Montani D; Duclos-Vallée JC; Samuel D; Humbert M; De Groote P; Sitbon O
J Hepatol; 2020 Jul; 73(1):130-139. PubMed ID: 32145258
[TBL] [Abstract][Full Text] [Related]
16. Portopulmonary hypertension.
Lv Y; Han G; Fan D
Scand J Gastroenterol; 2016 Jul; 51(7):795-806. PubMed ID: 27002212
[TBL] [Abstract][Full Text] [Related]
17. Portopulmonary hypertension: prognosis and management in the current treatment era - results from the REHAP registry.
Lazaro Salvador M; Quezada Loaiza CA; Rodríguez Padial L; Barberá JA; López-Meseguer M; López-Reyes R; Sala-Llinas E; Alcolea S; Blanco I; Escribano-Subías P;
Intern Med J; 2021 Mar; 51(3):355-365. PubMed ID: 31943676
[TBL] [Abstract][Full Text] [Related]
18. Current management approaches to portopulmonary hypertension.
Savale L; O'Callaghan DS; Magnier R; Le Pavec J; Hervé P; Jaïs X; Seferian A; Humbert M; Simonneau G; Sitbon O
Int J Clin Pract Suppl; 2011 Jan; (169):11-8. PubMed ID: 21176011
[TBL] [Abstract][Full Text] [Related]
19. Portopulmonary hypertension: a report from the US-based REVEAL Registry.
Krowka MJ; Miller DP; Barst RJ; Taichman D; Dweik RA; Badesch DB; McGoon MD
Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257
[TBL] [Abstract][Full Text] [Related]
20. Portopulmonary Hypertension in Liver Disease Presenting in Childhood.
Ecochard-Dugelay E; Lambert V; Schleich JM; Duché M; Jacquemin E; Bernard O
J Pediatr Gastroenterol Nutr; 2015 Sep; 61(3):346-54. PubMed ID: 25885880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]